Natural killer (NK)-resistant human lung cancer cells are lysed by recombinant interleukin-2-activated NK cells
Authors:
- Bruch W.S. RobinsonBRBruch W.S. Robinson
- 1 May 1987
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 106 (2) , 215-222
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- In vitro cytotoxicity and transplantation protection by autologous natural and activated killer cells against an in vitro transformed tumorigenic fibroblast line. A case study.Journal of Clinical Investigation, 1985
- Natural killer activity against cultured human neural tumor and fetal brain cellsCellular Immunology, 1985
- Modulation of human natural killer cell activity by recombinant human interleukin 2Cellular Immunology, 1985
- In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.The Journal of Immunology, 1984
- Natural killer cells are present in the normal human lung but are functionally impotent.Journal of Clinical Investigation, 1984
- Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cellsJournal of Experimental Medicine, 1983
- In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells.The Journal of Immunology, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.Journal of Experimental Medicine, 1982
- Diseases of the respiratory system. Neoplasms of the lung.BMJ, 1978